Source fact
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
0000313616-26-000161
Health Care · DHR
Danaher Corporation
Reported results, filing history, and direct access to the source documents.
LATEST QUARTERLY REPORT
10-Q · Period ended 2026-06-26
Filed 2026-07-21. Values below belong to this filing, not a rolling twelve-month estimate. Duration figures may cover a full year or year-to-date period.
Source fact
us-gaap:NetIncomeLoss
0000313616-26-000161
Source fact
us-gaap:Assets
0000313616-26-000161
Source fact
us-gaap:NetCashProvidedByUsedInOperatingActivities
0000313616-26-000161
LATEST ANNUAL REPORT
10-K · Period ended 2025-12-31
Filed 2026-02-24. Values below belong to this filing, not a rolling twelve-month estimate. Duration figures may cover a full year or year-to-date period.
Source fact
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
0000313616-26-000062
Source fact
us-gaap:NetIncomeLoss
0000313616-26-000062
Source fact
us-gaap:Assets
0000313616-26-000062
Source fact
us-gaap:NetCashProvidedByUsedInOperatingActivities
0000313616-26-000062
Disclosure timeline
Latest tracked 10-K, 10-Q, amendments, and earnings-related 8-K Item 2.02 filings. Amendments are listed but do not automatically replace the original report's facts.
8-K · Results of operations disclosure →Accession 0000313616-26-000163
10-Q · Period ended 2026-06-26 →Accession 0000313616-26-000161
8-K · Results of operations disclosure →Accession 0000313616-26-000109
10-Q · Period ended 2026-03-27 →Accession 0000313616-26-000107
10-K · Period ended 2025-12-31 →Accession 0000313616-26-000062
8-K · Results of operations disclosure →Accession 0000313616-26-000004
8-K · Results of operations disclosure →Accession 0000313616-26-000002
10-Q · Period ended 2025-09-26 →Accession 0000313616-25-000182
8-K · Results of operations disclosure →Accession 0000313616-25-000180
10-Q · Period ended 2025-06-27 →Accession 0000313616-25-000153
8-K · Results of operations disclosure →Accession 0000313616-25-000152
8-K · Results of operations disclosure →Accession 0000313616-25-000090
10-Q · Period ended 2025-03-28 →Accession 0000313616-25-000088
10-K · Period ended 2024-12-31 →Accession 0000313616-25-000043
8-K · Results of operations disclosure →Accession 0000313616-25-000004
8-K · Results of operations disclosure →Accession 0000313616-25-000002
8-K · Results of operations disclosure →Accession 0000313616-24-000223
10-Q · Period ended 2024-09-27 →Accession 0000313616-24-000220
8-K · Results of operations disclosure →Accession 0000313616-24-000188
10-Q · Period ended 2024-06-28 →Accession 0000313616-24-000186
8-K · Results of operations disclosure →Accession 0000313616-24-000106
10-Q · Period ended 2024-03-29 →Accession 0000313616-24-000102
10-K · Period ended 2023-12-31 →Accession 0000313616-24-000052
8-K · Results of operations disclosure →Accession 0000313616-24-000006
Read with context.
These are automatically extracted filing facts, not a complete financial review. Different companies and report types may use different reporting periods and accounting definitions. Missing values are not zero. No stock prices, earnings forecasts, or buy/sell ratings are provided.
All SEC filings for this company · Sources, coverage, and methodology
For education and research only. Not investment advice. Verify original filings before making decisions.